Hydroxycut(R) Recalled
Main Category: Liver Disease / HepatitisAlso Included In: Regulatory Affairs / Drug Approvals
Article Date: 19 May 2009 - 0:00 PDT
| Patient / Public: | ![]() |
3.67 (3 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
The U.S. Food and Drug Administration (FDA) announced the recall of 14 Hydroxycut® supplements due to reports of serious liver damage in patients who took the recommended dosages. Liver damage linked to Hydroxycut® use has resulted in at least one death and one liver transplant.
The recalled products are marketed as weight-loss supplements under the Iovate and MuscleTech brand names.
So far, the FDA has received more than 20 reports of serious health problems ranging from jaundice to liver failure. Symptoms of liver damage may include nausea, vomiting, light-colored stools, fatigue, weakness, abdominal pain, itching and loss of appetite. Other adverse effects that have been reported include seizures; heart problems and rhabdomyolysis, a type of muscle damage that may lead to kidney failure.
The FDA has not determined which ingredients or other factors may be associated with the reported health risks.
The recalled products include:
- Hydroxycut Regular Rapid Release Caplets®
- Hydroxycut Caffeine-Free Rapid Release Caplets®
- Hydroxycut Hardcore Liquid Caplets®
- Hydroxycut Max Liquid Caplets®
- Hydroxycut Regular Drink Packets®
- Hydroxycut Caffeine-Free Drink Packets®
- Hydroxycut Hardcore Drink Packets® (Ignition Stix)
- Hydroxycut Max Drink Packets®
- Hydroxycut Liquid Shots®
- Hydroxycut Hardcore® RTDs (Ready-to-Drink)
- Hydroxycut Max Aqua Shed®
- Hydroxycut 24®
- Hydroxycut Carb Control®
- Hydroxycut Natural®
Hydroxycut Cleanse® and Hoodia® products, two other products marketed under the Iovate or MuscleTech brands, are not affected by the recall.
References:
1. Natural Standard: The Authority on Integrative Medicine. http://www.naturalstandard.com. Copyright © 2009.
2. U.S. Food and Drug Administration (FDA). http://www.fda.gov
Source
Natural Standard
Visit our liver disease / hepatitis section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/150461.php>
APA
http://www.medicalnewstoday.com/releases/150461.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




